FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2022/02/040375 [Registered on: 17/02/2022] Trial Registered Prospectively
Last Modified On: 14/02/2022
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Siddha 
Study Design  Single Arm Study 
Public Title of Study   A clinical trial on Vasambu Chooranam in the management of Erigunmam (PEPTIC ULCER DISEASE) 
Scientific Title of Study   A PROSPECTIVE OPEN LABELLED,NON-RANDOMIZED,PHASE II CLINICAL TRIAL OF VASAMBU CHOORANAM IN THE MANAGEMENT OF ERI GUNMAM (PEPTIC ULCER DISEASE) 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  PGomathi 
Designation  PG scholar 
Affiliation  Government Siddha Medical College and Hospital Palayamkottai 
Address  PG Department of Pothu Maruthuvam OP NO.10 Government Siddha Medical College and Hospital Palayamkottai Tirunelveli
PG Department of Pothu Maruthuvam OP no.10 Government Siddha Medical College and Hospital Palayamkottai Tirunelveli
Tirunelveli
TAMIL NADU
627002
India 
Phone  6381162926  
Fax    
Email  gomezz1997@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Dr A Manoharan MD s PhD 
Designation  Professor and HOD 
Affiliation  Government Siddha Medical College and Hospital Palayamkottai 
Address  PG Department of Pothu Maruthuvam OP No.10 Government Siddha Medical College and Hospital Palayamkottai Tirunelveli.
PG Department of Pothu Maruthuvam OP no.10 Government Siddha Medical College and Hospital Palayamkottai Tirunelveli.
Tirunelveli
TAMIL NADU
627002
India 
Phone  9443886700  
Fax    
Email  drmanoharan25@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Dr A Manoharan MD s PhD 
Designation  Professor and HOD 
Affiliation  Government Siddha Medical College and Hospital Palayamkottai 
Address  PG Department of Pothu Maruthuvam OP no.10 Government Siddha Medical College and Hospital Palayamkottai Tirunelveli
PG Department of Pothu Maruthuvam OP No.10 Government Siddha Medical College and Hospital Palayamkottai Tirunelveli
Tirunelveli
TAMIL NADU
627002
India 
Phone  9443886700  
Fax    
Email  drmanoharan25@gmail.com  
 
Source of Monetary or Material Support  
OPD and IPD facilities and Central Library of Government Siddha Medical College and Hospital  
 
Primary Sponsor  
Name  Government Siddha Medical College and Hospital 
Address  Government Siddha Medical College and Hospital Palayamkottai Tirunelveli Tamilnadu 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
PGomathi  Government Siddha Medical College and Hospital  PG Department of Pothu Maruthuvam OP no 10
Tirunelveli
TAMIL NADU 
6381162926

gomezz1997@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K279||Peptic ulcer, site unspecified, unspecified as acute or chronic, without hemorrhage or perforation,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  NIL  NIL 
Intervention  VASAMBU CHOORANAM  0.5g - 1g twice a day (orally) A/F 45 days along with honey as adjuvant 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  1.Patients having symptoms of epigastric pain,heart burn,nausea,vomiting,loss of weight,water brash, indigestion and bloating of abdomen
2.Patients who are willing to take upper gastrointestinal endoscopy
3.Patients who are willing to give blood specimen and laboratory investigation when required 
 
ExclusionCriteria 
Details  1.Pregnancy
2.lactating mother
3.Diabetes Mellitus
4.Recent malignancy or radiation therapy
5.Gastro esophageal reflux disease
6.Pancreatitis
7.Inflammatory Bowel Disease
8.Acute hepatitis
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
If during treatment or after treatment reduction of the following symptoms
1.Epigastric pain
2.heart burn
3.nausea
4.vomiting
5.water brash
6.loss of weight
7.indigestion
8.bloating of abdomen 
45 days 
 
Secondary Outcome  
Outcome  TimePoints 
To evaluate the biochemical and physio-chemical and phytochemical analysis of clinical trial drug
To evaluate the antimicrobial activity of trial drug
To evaluate the safety profile for acute and sub acute toxicity of the trial drug Vasambu Chooranam
To evaluate pharmacological analysis of the clinical trial drug
To evaluate siddha parameters and modern parameters during the treatment of Peptic Ulcer Disease with trial drug
To evaluate the statistical analysis of the clinical trial drug Vasambu Chooranam
To evaluate the powder microscopic study and HTPLC of the trial drug 
45 days 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   24/02/2022 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   The study is a prospective open labelled phase ll Non randomised clinical study to evaluate the therapeutic efficacy of Vasambu Chooranam in the management of Erigunmam(Peptic Ulcer Disease).The trial drug will be administered at the dose of 0.5g -1g twice a day (orally) A/F 45 days along with Honey as adjuvant in 40 patients.The trial period of 12 months will be carried out in Government Siddha Medical College and Hospital Palayamkottai, Tirunelveli, Tamil Nadu.The secondary outcome will be the evaluation of siddha diagnostic parameters , assessment of safety profile of trial drug, assessment of pharmacological and biochemical parameters of trial drug.In case of any adverse events (AE) is noticed and it will be referred to Pharamacovigilance department of SCRI.Further management of Patients will be given in OPD facility 
Close